Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Wynter, E.A.
Right arrow Articles by Testa, N.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Wynter, E.A.
Right arrow Articles by Testa, N.G.
Stem Cells, Vol. 16, No. 5, 349-356, September 1998
© 1998 AlphaMed Press

Differential Response of CD34+ Cells Isolated from Cord Blood and Bone Marrow to MIP-1{alpha} and the Expression of MIP-1{alpha} Receptors on These Immature Cells

E.A. de Wynter, J. Durig, M.A. Cross, C.M. Heyworth, N.G. Testa

CRC Section of Haemopoietic Cell and Gene Therapeutics, Paterson Institute for Cancer Research, Wilmslow Road, Manchester, United Kingdom

Key Words. MIP-1{alpha} receptors • Chemokines • Hemopoietic cells • Cell cycle

Dr. E.A. de Wynter, CRC Section of Haemopoietic Cell and Gene Therapeutics, Paterson Institute for Cancer Research, Wilmslow Road, Withington, Manchester, M20 4BX, United Kingdom.

Macrophage inflammatory protein-1 alpha (MIP-1{alpha}) has been shown to have a role in the control of myeloid stem and progenitor cell proliferation. Recent evidence suggests that MIP-1{alpha} also has a stimulatory effect on proliferation of mature progenitors as well as an inhibitory effect on immature progenitors in vitro. We have compared the effect of MIP-1{alpha} on myeloid and erythroid colony formation of CD34+ cells isolated from bone marrow and cord blood. In the presence of MIP-1{alpha}, bone marrow granulocyte-macrophage-colony forming cells (GM-CFC) were inhibited over a dose range of 15 ng/ml to 500 ng/ml, and GM-CFC from cord blood CD34+ cells were stimulated over the same dose range. MIP-1{alpha} suppressed BFU-E colonies in both bone marrow and cord blood. Using thymidine suicide assays, the influence of MIP-1{alpha} on the cycling status of the cells was assessed. A good correlation between the effect of MIP-1{alpha} on colony formation and cell cycle progression was observed. These results suggest that there is a differential response to MIP-1{alpha} when bone marrow and cord blood CD34+ cells are compared.

Using flow cytometry and a biotinylated human MIP-1{alpha}/avidin fluorescein conjugate, the expression of MIP-1{alpha} receptors on CD34+ cells was assessed. The data indicated that there was little quantitative difference in overall expression of receptors (82.9% versus 93%) from bone marrow or cord blood, respectively. However, when Northern blot analysis was used, mRNA for two different MIP-1{alpha} receptors CCR1 and CCR5 could be detected in bone marrow, but only CCR1 mRNA was seen in cord blood CD34+ samples. Therefore, the expression of different receptor subtypes on CD34+ cells may be responsible for the difference in MIP-1{alpha} responsiveness observed.




This article has been cited by other articles:


Home page
Cancer Res.Home page
L. De Felice, C. Tatarelli, M. G. Mascolo, C. Gregorj, F. Agostini, R. Fiorini, V. Gelmetti, S. Pascale, F. Padula, M. T. Petrucci, et al.
Histone Deacetylase Inhibitor Valproic Acid Enhances the Cytokine-Induced Expansion of Human Hematopoietic Stem Cells
Cancer Res., February 15, 2005; 65(4): 1505 - 1513.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
S. Chaisavaneeyakorn, J. M. Moore, L. Mirel, C. Othoro, J. Otieno, S. C. Chaiyaroj, Y. P. Shi, B. L. Nahlen, A. A. Lal, and V. Udhayakumar
Levels of Macrophage Inflammatory Protein 1{alpha} (MIP-1{alpha}) and MIP-1{beta} in Intervillous Blood Plasma Samples from Women with Placental Malaria and Human Immunodeficiency Virus Infection
Clin. Vaccine Immunol., July 1, 2003; 10(4): 631 - 636.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Lamkhioued, S. G. Abdelilah, Q. Hamid, N. Mansour, G. Delespesse, and P. M. Renzi
The CCR3 Receptor Is Involved in Eosinophil Differentiation and Is Up-Regulated by Th2 Cytokines in CD34+ Progenitor Cells
J. Immunol., January 1, 2003; 170(1): 537 - 547.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. A. de Wynter, C. M. Heyworth, N. Mukaida, E. Jaworska, A. Weffort-Santos, K. Matushima, and N. G. Testa
CCR1 chemokine receptor expression isolates erythroid from granulocyte-macrophage progenitors
J. Leukoc. Biol., September 1, 2001; 70(3): 455 - 460.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Majka, J. Ratajczak, B. Lee, M. Honczarenko, R. Douglas, M. A. Kowalska, L. Silberstein, A. M. Gewirtz, and M. Z. Ratajczak
The Role of HIV-Related Chemokine Receptors and Chemokines in Human Erythropoiesis in Vitro
Stem Cells, March 1, 2000; 18(2): 128 - 138.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 1998 by AlphaMed Press.